Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Cheol-Hyung Lee"'
Autor:
Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim
Publikováno v:
Clinical and Molecular Hepatology, Vol 26, Iss 3, Pp 328-339 (2020)
Background/Aims Several treatment options are currently available for patients with hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare the effectiveness of regorafenib and nivolumab in these patients. Methods Con
Externí odkaz:
https://doaj.org/article/3138d905ffa24a509b07d0f5b4238808
Autor:
Su Jong Yu, Jeong Hoon Lee, S.-W. Kim, Heejoon Jang, Minseok Albert Kim, Jung Hwan Yoon, Yoon Jun Kim, Tae-You Kim, Hyunwoo Oh, Kyung Hun Lee, Yun Bin Lee, Eun Ju Cho, Cheol Hyung Lee
Publikováno v:
Clinical and Molecular Hepatology
Clinical and Molecular Hepatology, Vol 26, Iss 3, Pp 328-339 (2020)
Clinical and Molecular Hepatology, Vol 26, Iss 3, Pp 328-339 (2020)
Background/Aims: Several treatment options are currently available for patients with hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare the effectiveness of regorafenib and nivolumab in these patients.Methods: Co
Autor:
Seung Up Kim, Kwang Hyub Han, Jung Hwan Yoon, Cheol Hyung Lee, Jeong Hoon Lee, Do Young Kim, Yun Bin Lee, Eun Ju Cho, Sang Hoon Ahn, Beom Kyung Kim, Yoon Jun Kim, Su Jong Yu, Ho Soo Chun, Jun Yong Park
Publikováno v:
European Journal of Gastroenterology & Hepatology. 32:378-385
OBJECTIVES Hepatocellular carcinoma can develop after hepatitis C virus eradication. We developed a new hepatocellular carcinoma risk score (HCC-SVR score) based on independent predictors for chronic hepatitis C after sustained virological response.
Autor:
Jung Hwan Yoon, Cheol-Hyung Lee, Minseok Albert Kim, Heejoon Jang, Yun Bin Lee, Jeong Hoon Lee, Joon Yeul Nam, Eun Ju Cho, S.-W. Kim, Hyo Cheol Kim, Hyunwoo Oh, Jin Wook Chung, Su Jong Yu, Young Youn Cho, Yoon Jun Kim, Youngsu Park, Min Kyung Park, Sung Won Chung
Publikováno v:
Journal of Hepatocellular Carcinoma
Sung Won Chung,1,* Min Kyung Park,1,* Young Youn Cho,1,2,* Youngsu Park,1 Cheol-Hyung Lee,1 Hyunwoo Oh,1 Heejoon Jang,1 Minseok Albert Kim,1 Sun Woong Kim,1 Joon Yeul Nam,1 Yun Bin Lee,1 Eun Ju Cho,1 Su Jong Yu,1 Hyo-Cheol Kim,3 Yoon Jun Kim,1 Jin Wo
Autor:
Yun Bin Lee, Cheol-Hyung Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeonghoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim
Publikováno v:
Journal of Hepatology. 73:S913-S914
Autor:
Hyunwoo Oh, Yoon Jun Kim, Cheol-Hyung Lee, Minseok Albert Kim, Heejoon Jang, Sun Woong Kim, Yun Bin Lee, Eun Ju Cho, Jeonghoon Lee, Su Jong Yu, Jung-Hwan Yoon
Publikováno v:
Journal of Hepatology. 73:S582-S583
Autor:
Yun Bin Lee, Jeonghoon Lee, Hyo Young Lee, Cheol-Hyung Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Suk Kyun Hong, Eun Ju Cho, Su Jong Yu, Nam-Joon Yi, Kwang-Woong Lee, Jong Man Kim, Yoon Jun Kim, Kyung-Suk Suh, Jung-Hwan Yoon
Publikováno v:
Journal of Hepatology. 73:S397-S398
Autor:
Sun Woong Kim, Jun Yong Park, Yong Jin Jung, Jeonghoon Lee, Jae Seung Lee, Jisoo Song, Han Ah Lee, Yeon Seok Seo, Minjong Lee, Dae Hee Choi, Moon Young Kim, Seong Hee Kang, Jin Mo Yang, Do Seon Song, Jun Sik Yoon, Minseok Albert Kim, Hyunwoo Oh, Heejoon Jang, Cheol-Hyung Lee, Sungwon Chung, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon
Publikováno v:
Journal of Hepatology. 73:S769-S770
Autor:
Jung Hwan Yoon, Joon Yeul Nam, S.-W. Kim, Hyo Cheol Kim, Su Jong Yu, Young Jun Chang, Jeong Hoon Lee, Jun Sik Yoon, Hyo Young Lee, Hwi Young Kim, Yun Bin Lee, Eun Ju Cho, Jin Wook Chung, Cheol Hyung Lee, Yoon Jun Kim, Dong Hyun Sinn
Publikováno v:
Cancers
Volume 11
Issue 11
Cancers, Vol 11, Iss 11, p 1721 (2019)
Volume 11
Issue 11
Cancers, Vol 11, Iss 11, p 1721 (2019)
Background: For patients with hepatocellular carcinoma (HCC), the definition of refractoriness to transarterial chemoembolization (TACE), which might make them a candidate for systemic therapy, is still controversial. We aimed to derive and validate
Autor:
Jung Hwan Yoon, Yun Bin Lee, Eun Ju Cho, Jun Sik Yoon, Dae Hee Choi, Minjong Lee, Moon Young Kim, Jisoo Song, Jeong Hoon Lee, S.-W. Kim, Hee Joon Jang, Su Jong Yu, Yeon Seok Seo, Sung Won Chung, Jin Mo Yang, Minseok Albert Kim, Yong Jin Jung, Cheol Hyung Lee, Jin Myung Park, Jae Seung Lee, Han Ah Lee, Hyunwoo Oh, Yoon Jun Kim, Jun Yong Park, Do Seon Song, Seong Hee Kang
Publikováno v:
Clinical Gastroenterology and Hepatology. 19:976-986.e5
Background & Aims Third-generation cephalosporins (TGCs) are recommended as first-line antibiotics for treatment of spontaneous bacterial peritonitis (SBP). However, antibiotics against multidrug-resistant organisms (such as carbapenems) might be nec